Product name:Roflumilast Chemical name:3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide CAS No.:162401-32-3 Specification:99.0%HPLC Molecular Formula:C17H14Cl2F2N2O3 Molecular Weight:403.21 Appearance: white powder Usage:On March 1,2011, the FDA approved the chronic obstructive pneumonia drug Daliresp (roflumilast), the drug used daily, can reduce asthma attack frequency or mitigate serious chronic obstructive pneumonia (COPD) symptoms.Roflumilast is a new category of COPD drug, phosphodiesterase - 4 (PDE - 4) inhibitors. Can be used among patients with serious COPD cough and bronchial symptom related much sputum, does not apply to mild emphysema.

CAS NO:138530-94-6

EC NO:

Molecular Formula:C₁₆H₁₄F₃N₃O₂S

Molecular Weight:369.36

Synonyms:;(R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;1H-Benzimidazole, 2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, (R)-;Dexlansoprazole;2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;T 168390;TAK 390;(R)-Lansoprazole;(R)-Lansorprazole

Molecular Structure: